Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Non-melanoma Skin Cancer 2Skin Neoplasms 1Neurofibromatosis 1 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lung Neoplasms 1Hand-Foot Syndrome 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

AZD 6244 9trametinib 3mirdametinib 3Lovastatin 3Sirolimus 2Inhalation 2Everolimus 2Acetylcysteine 2tipifarnib 1thymoglobulin 1pirfenidone 1peginterferon alfa-2b 1omipalisib 1fludarabine 1cediranib 1binimetinib 1Vitamin D 1Vincristine 1Vinblastine 1Temozolomide 1Sunitinib 1Saline Solution 1Rituximab 1Radiotherapy 1Radiation 1Photochemotherapy 1N-monoacetylcystine 1Methotrexate 1Melphalan 1Levetiracetam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neurofibromatosis 1 × Diclofenac × Clear all
NCT03090971 2017-10-26

Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1

Fundação Educacional Serra dos Órgãos

Phase 2 Completed
7 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡